Using NS5B Sequencing for Hepatitis C Virus Genotyping Reveals Discordances with Commercial Platforms.
about
Comparison of Three Different Hepatitis C Virus Genotyping Methods: 5'NCR PCR-RFLP, Core Type-Specific PCR, and NS5b Sequencing in a Tertiary Care Hospital in South India.The cobas® HCV GT is a new tool that accurately identifies Hepatitis C virus genotypes for clinical practice.Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000-2015 period (the GEHEP 005 study).NS3 genomic sequencing and phylogenetic analysis as alternative to a commercially available assay to reliably determine hepatitis C virus subtypes 1a and 1b.Next-Generation Sequencing: a Diagnostic One-Stop Shop for Hepatitis C?Genotype and genetic variation of HCV infections with low-risk factors in Putian coastal regions, China.Evaluation of the cobas® GT hepatitis C virus genotyping assay in G1-6 viruses including low viral loads and LiPA failures.Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysisPipeline for specific subtype amplification and drug resistance detection in hepatitis C virus
P2860
Q36118779-B16383BB-543D-4A5D-B2A6-85AEB5507512Q36347235-8B8E6CD9-51DC-4C37-8266-72A6826BEBF6Q38935930-D3A62803-6146-4AAC-9584-061F78FA88C6Q40104062-34CBE53E-FF0D-46AF-B2E0-63FADE39DB7FQ40627402-D5FD5BA1-E3E3-4DF5-AF75-9962E15A0CF1Q47596851-5950A3B3-6F77-4FA9-BE30-0C9155E6B873Q52346277-BE544E06-0A9A-4F1A-9F75-74E505A6B6BDQ56782091-30319C01-06EE-4131-80E6-65487EFF6A78Q58768677-029F9750-8EC9-448E-9147-024851B19202
P2860
Using NS5B Sequencing for Hepatitis C Virus Genotyping Reveals Discordances with Commercial Platforms.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Using NS5B Sequencing for Hepa ...... ces with Commercial Platforms.
@ast
Using NS5B Sequencing for Hepa ...... ces with Commercial Platforms.
@en
type
label
Using NS5B Sequencing for Hepa ...... ces with Commercial Platforms.
@ast
Using NS5B Sequencing for Hepa ...... ces with Commercial Platforms.
@en
prefLabel
Using NS5B Sequencing for Hepa ...... ces with Commercial Platforms.
@ast
Using NS5B Sequencing for Hepa ...... ces with Commercial Platforms.
@en
P2093
P2860
P50
P1433
P1476
Using NS5B Sequencing for Hepa ...... ces with Commercial Platforms.
@en
P2093
Federico García
Isidro Rivadulla
Javier Rodriguez-Granjer
Jose Angel Fernandez-Caballero
Juan Carlos Galán
Laura Cardeñoso
Marta Alvarez
Miriam Fernandez-Alonso
Rubén Lovatti
P2860
P304
P356
10.1371/JOURNAL.PONE.0153754
P407
P577
2016-04-20T00:00:00Z